{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:28:45Z","timestamp":1790231325890,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The rapid expansion of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use for weight management and diabetes has raised perioperative questions, particularly regarding delayed gastric emptying and infection risk. Emerging real-world data suggest a more nuanced perioperative profile. This scoping review synthesizes evidence on preoperative GLP-1 RA exposure and postoperative outcomes across orthopaedic procedures, with emphasis on soft-tissue sports medicine, and is intended to map associative perioperative outcomes rather than establish causality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Following Arksey-O'Malley and Joanna Briggs Institute methodology and PRISMA-ScR reporting, we searched PubMed, Scopus, Web of Science, CINAHL Ultimate, Academic Search Premier, and Ovid Emcare (2015 to 2025). Eligible studies evaluated adult orthopaedic patients with documented GLP-1 RA use and postoperative outcomes. Three reviewers independently screened and extracted study characteristics, exposure timing, perioperative management, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 117 records screened, 35 studies met inclusion. Most were large retrospective cohorts spanning arthroplasty, spine fusion, trauma fixation, foot\/ankle fusion, shoulder arthroplasty, and rotator cuff repair. Across hip, knee, and shoulder arthroplasty, GLP-1 RA use was generally associated with similar or lower 90-day complications, reduced periprosthetic joint infection, shorter length of stay, and fewer readmissions or revisions. Spine findings were mixed: Several cohorts showed lower infection and readmission, while others noted increased pneumonia, acute kidney injury, or pseudarthrosis in long-term semaglutide users. Trauma and ankle fracture cohorts showed no increase in short-term complications and in some cases lower mortality, with isolated signals for increased late fall-related injuries. Soft-tissue cohorts (rotator cuff repair and distal radius fixation) demonstrated fewer adverse events without increased aspiration or revision surgery risk. Functional outcomes (PROMIS) were rarely reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Preoperative GLP-1 RA exposure is not broadly associated with increased postoperative risk and often correlates with lower infection, readmission, and mortality rates\u2014particularly in arthroplasty, spine, and ankle fracture fixation cohorts. Findings in spine surgery are more mixed and warrant cautious interpretation, especially with prolonged semaglutide exposure. Outcomes in sports-medicine procedures seem reassuring, although prospective multicenter studies with standardized perioperative protocols and PROMIS-based outcomes are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01571","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:00:33Z","timestamp":1775214033000},"page":"e1792-e1808","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes in Orthopaedic Surgery: A Scoping Review of Perioperative and Recovery Outcomes"],"prefix":"10.5435","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2434-0492","authenticated-orcid":false,"given":"Isabella","family":"Strickler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Cragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McNassor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Guettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bicos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"e175634","DOI":"10.1172\/JCI175634","article-title":"The GLP-1 journey: From discovery science to therapeutic impact","volume":"134","author":"Drucker","year":"2024","journal-title":"J Clin Invest"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"e00321","DOI":"10.1097\/XCE.0000000000000321","article-title":"GLP-1 receptor agonists and delayed gastric emptying: Implications for invasive cardiac interventions and surgery","volume":"14","author":"Shankar","year":"2025","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.3390\/jcm13164674","article-title":"Cardiovascular protective properties of GLP-1 receptor agonists: More than just diabetic and weight loss drugs","volume":"13","author":"Le","year":"2024","journal-title":"J Clin Med"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.obpill.2024.100127","article-title":"Glucagon-like peptide-1 receptor agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks","volume":"12","author":"Ghusn","year":"2024","journal-title":"Obes Pillars"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/anae.16306","article-title":"Glucagon-like peptide-1 receptor agonists: A narrative review of clinical pharmacology and implications for peri-operative practice","volume":"79","author":"Milder","year":"2024","journal-title":"Anaesthesia"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s12891-025-08742-5","article-title":"Risk factors for general complications after hip or knee replacement surgery in elderly patients: A single-center study","volume":"26","author":"Zhang","year":"2025","journal-title":"BMC Musculoskelet Disord"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1227\/neu.0000000000003291","article-title":"Perioperative glucagon-like peptide-1 agonist use and rates of pseudarthrosis after single-level lumbar fusion: A large retrospective cohort study","volume":"97","author":"Agrawal","year":"2024","journal-title":"Neurosurgery"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.joca.2019.10.005","article-title":"Greater risks of complications, infections, and revisions in the Obese versus non-obese total hip arthroplasty population of 2,190,824 patients: A meta-analysis and systematic review","volume":"28","author":"Onggo","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/CORR.0000000000001389","article-title":"What are risk factors for infection after primary or revision total joint arthroplasty in patients older than 80 years?","volume":"478","author":"Sodhi","year":"2020","journal-title":"Clin Orthop Relat Res"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1749-799X-9-15","article-title":"Risk factors for postoperative complication after spinal fusion and instrumentation in degenerative lumbar scoliosis patients","volume":"9","author":"Tang","year":"2014","journal-title":"J Orthop Surg Res"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/medicina60111757","article-title":"Influence of diabetes mellitus on postoperative complications after total knee arthroplasty: A systematic review and meta-analysis","volume":"60","author":"Hong","year":"2024","journal-title":"Medicina"},{"key":"R13-20260622","first-page":"e70051","article-title":"Comparison of SGLT2 inhibitors versus GLP-1 receptor agonists and risks of osteoarthritis and arthroplasty in type 2 diabetes mellitus","volume":"40","author":"Su","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/BRS.0000000000005099","article-title":"No difference in short-term outcomes from semaglutide treatment after cervical decompression and fusion","volume":"50","author":"Tao","year":"2025","journal-title":"Spine (Phila Pa 1976)"},{"key":"R15-20260622","first-page":"2213","article-title":"GLP-1 receptor agonists decrease medical and surgical complications in morbidly Obese patients undergoing primary TKA","volume":"106","author":"Kim","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.spinee.2024.06.543","article-title":"Semaglutide associated with improved postoperative outcomes following single-level posterior lumbar fusion for patients with type II diabetes","volume":"24","author":"Seddio","year":"2024","journal-title":"Spine J"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: Towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.sart.2024.10.001","article-title":"The impact of GLP-1 receptor agonists on postoperative outcomes following total shoulder arthroplasty","volume":"35","author":"Choudhury","year":"2025","journal-title":"Semin Arthroplasty"},{"key":"R19-20260622","article-title":"Does use of GLP-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?","author":"Elsabbagh","year":"2024","journal-title":"J Shoulder Elbow Surg"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00590-025-04477-0","article-title":"Slimming the risks: GLP-1 receptor agonist therapy may reduce in-hospital complications and readmission rates for hip fractures compared with Obese patients not on these medications","volume":"35","author":"Goldstein","year":"2025","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.arth.2024.10.099","article-title":"GLP-1 receptor agonist use is not associated with increased complications after total hip arthroplasty in patients with type 2 diabetes","volume":"40","author":"Heo","year":"2025","journal-title":"J Arthroplasty"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.arth.2025.02.042","article-title":"Trends, demographics, and outcomes for GLP-1 receptor agonist use in total knee arthroplasty: An 11-year perspective","volume":"40","author":"Katzman","year":"2025","journal-title":"J Arthroplasty"},{"key":"R23-20260622","first-page":"e89183","article-title":"GLP-1 receptor agonist use in patients undergoing distal radius fracture surgery: A retrospective review of perioperative considerations","volume":"17","author":"Khak","year":"2025","journal-title":"Cureus"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"108952","DOI":"10.1016\/j.clineuro.2025.108952","article-title":"Impact of semaglutide use for weight loss on TLIF outcomes","volume":"242","author":"Khalid","year":"2025","journal-title":"Clin Neurol Neurosurg"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.arth.2024.12.008","article-title":"Utilization of GLP-1 receptor agonists at the time of total hip arthroplasty for patients with morbid obesity","volume":"40","author":"Kim","year":"2025","journal-title":"J Arthroplasty"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.arth.2024.06.008","article-title":"The five-year incidence of progression to osteoarthritis and total joint arthroplasty in patients prescribed glucagon-like Peptide-1 receptor agonists","volume":"39","author":"Lavu","year":"2024","journal-title":"J Arthroplasty"},{"key":"R27-20260622","first-page":"e495","article-title":"GLP-1 receptor agonist use and perioperative complications following shoulder arthroplasty","volume":"33","author":"Lawand","year":"2024","journal-title":"J Shoulder Elbow Surg"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/10711007251328370","article-title":"GLP-1 agonists' effect on infection and union after foot and ankle fusion procedures","volume":"46","author":"Levidy","year":"2025","journal-title":"Foot Ankle Int"},{"key":"R29-20260622","first-page":"e41243","article-title":"Glucagon-like peptide-1 receptor agonist therapy to attenuate the risk of knee osteoarthritis and total knee replacement in type 2 diabetes mellitus: A nation-wide cohort study","volume":"103","author":"Lin","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"key":"R32-20260622","first-page":"A09240629","article-title":"Perioperative GLP-1RA management and aspiration risk in patients with diabetes undergoing fast-track hip and knee arthroplasty","volume":"72","author":"Mahmoud","year":"2025","journal-title":"Danish Med J"},{"key":"R33-20260622","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.jfas.2025.05.002","article-title":"Impact of GLP-1 receptor agonists on postoperative outcomes following ankle fracture ORIF","volume":"64","author":"Morningstar","year":"2025","journal-title":"J Foot Ankle Surg"},{"key":"R34-20260622","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.spinee.2025.03.023","article-title":"Semaglutide use is associated with higher rates of pseudarthrosis and dysphagia after posterior cervical fusion","volume":"25","author":"Ng","year":"2025","journal-title":"Spine J"},{"key":"R35-20260622","doi-asserted-by":"crossref","first-page":"112746","DOI":"10.1016\/j.injury.2025.112746","article-title":"Perioperative GLP-1 receptor agonist use and long-term outcomes following lower extremity fracture fixation","volume":"56","author":"Pereira","year":"2025","journal-title":"Injury"},{"key":"R36-20260622","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.knee.2025.08.007","article-title":"GLP-1 agonists are protective against postoperative complications following total knee arthroplasty","volume":"57","author":"Ranson","year":"2025","journal-title":"Knee"},{"key":"R37-20260622","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jor.2025.08.016","article-title":"GLP-1 receptor agonist use is not associated with increased reoperation risk following rotator cuff repair","volume":"70","author":"Rasmussen","year":"2025","journal-title":"J Orthop"},{"key":"R38-20260622","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.spinee.2024.10.011","article-title":"Semaglutide utilization associated with reduced 90-day postoperative complications following single-level posterior lumbar fusion","volume":"25","author":"Seddio","year":"2025","journal-title":"Spine J"},{"key":"R39-20260622","first-page":"2031","article-title":"Lower risk of postoperative complications and rotator cuff retear associated with semaglutide use in type 2 diabetes mellitus","volume":"40","author":"Seddio","year":"2024","journal-title":"Arthroscopy"},{"key":"R40-20260622","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.5435\/JAAOS-D-25-00439","article-title":"Reduced 90-day cardiovascular and infectious complications after ankle ORIF with preoperative semaglutide","volume":"33","author":"Seddio","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"key":"R41-20260622","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jseint.2024.10.006","article-title":"Improved total shoulder arthroplasty outcomes associated with semaglutide in diabetes patients","volume":"9","author":"Seddio","year":"2025","journal-title":"JSES Int"},{"key":"R42-20260622","first-page":"1241","article-title":"Short-term complications of preoperative weight-loss strategies in total knee arthroplasty: Bariatric surgery versus GLP-1 receptor agonists","volume":"40","author":"Sharma","year":"2025","journal-title":"J Arthroplasty"},{"key":"R43-20260622","first-page":"e70008","article-title":"Gastric ultrasound to assess the prokinetic efficacy of erythromycin in a patient taking GLP-1 receptor agonists","volume":"12","author":"Sidhu","year":"2024","journal-title":"Anesth Rep"},{"key":"R44-20260622","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.arth.2025.03.012","article-title":"GLP-1 agonists for weight loss: Do they increase complications in non-diabetic patients undergoing primary total hip arthroplasty?","volume":"40","author":"Verhey","year":"2025","journal-title":"J Arthroplasty"},{"key":"R45-20260622","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1177\/10711007251364187","article-title":"Preoperative GLP-1 receptor agonist use and postoperative outcomes following operative ankle fracture repair in patients with type 2 diabetes: A national database study","volume":"46","author":"White","year":"2025","journal-title":"Foot Ankle Int"},{"key":"R46-20260622","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/BRS.0000000000005283","article-title":"GLP-1 receptor agonist medications alter outcomes of spine surgery: Analysis of 15,000+ patients","volume":"50","author":"Wiener","year":"2025","journal-title":"Spine (Phila Pa 1976)"},{"key":"R47-20260622","doi-asserted-by":"crossref","first-page":"e2461200","DOI":"10.1001\/jamanetworkopen.2024.61200","article-title":"Postoperative weight loss after anti-obesity medications and revision risk after joint replacement","volume":"8","author":"Xie","year":"2025","journal-title":"JAMA Netw Open"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:51:02Z","timestamp":1787669462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":47,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01571","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}